We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by AFT Pharmaceuticals Ltd
I, Leanne McCauley, Delegate of the Secretary to the Department of Health, on receipt of an application from AFT Pharmaceuticals Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representations described in paragraphs (a) below for use in advertisements directed to consumers, for the product identified in paragraphs (b):
- For the temporary relief of pain associated with arthritis/osteoarthritis
- MAXIGESIC film coated tablet blister pack (AUST R 218785)
Dated this 20th day of May 2019
Signed electronically
Leanne McCauley
Delegate of the Secretary to the Department of Health
Advertising Compliance Unit
Regulatory Education and Compliance Branch